MedStar Georgetown University Hospital is the first hospital in the Washington metropolitan area to offer Tumor-Infiltrating Lymphocyte therapy, or TIL therapy, to treat metastatic melanoma. This breakthrough, life-saving cancer treatment uses a patient’s own tumor and immune system to fight their cancer. Watch this video to see Dr. Geoffrey Gibney, leader of the Melanoma Disease Group at MedStar Georgetown, explain how this FDA-approved treatment provides a chance for durable, long-term respons

What is a tumor-infiltrating lymphocyte? Learn about this immune cell that can recognize and kill cancer cells. | National Cancer Institute

As part of our IMPACT Program at Oasis of Hope, Tumor-Infiltrating Lymphocytes (TIL) Immunotherapy empowers the body’s own immune system to fight cancer: 🔬 A small tumor sample is collected, containing lymphocytes (TILs) that have already recognized cancer cells. 🔬 These TILs are carefully isolated and expanded in our immunotherapy lab, multiplied from thousands to millions. 🔬 Once activated, they are reinfused into the patient, returning to the tumor with greater potency, durability, and pre